Sort   by:  
 Page size 
UnknownImpact of Polymorphism of CYP2D6 on Equilibrium Concentration of Duloxetine in Patients Suffering from Major Depressive Disorder.
Not available
S-EPMC7377539 | biostudies-literature
UnknownThe Influence of Concentration of Micro-RNA hsa-miR-370-3p and CYP2D6*4 on Equilibrium Concentration of Mirtazapine in Patients With Major Depressive Disorder.
Not available
S-EPMC7377541 | biostudies-literature
UnknownImpact of the Omics-Based Biomarkers on the Fluvoxamine's Steady-State Concentration, Efficacy and Safety in Patients with Affective Disorders Comorbid with Alcohol Use Disorder.
Not available
S-EPMC8063127 | biostudies-literature
UnknownImpact of the Omics-Based Biomarkers on the Mirtazapine's Steady-State Concentration, Efficacy and Safety in Patients with Affective Disorders Comorbid with Alcohol Use Disorder.
Not available
S-EPMC8146558 | biostudies-literature
UnknownCorrelation of 1846G>A Polymorphism of CYP2D6 Gene with Haloperidol Efficacy and Safety in Patients with Alcoholic Hallucinoses.
Not available
S-EPMC9235315 | biostudies-literature
UnknownOlanzapine-Associated Rhabdomyolysis: A Case Report.
Not available
S-EPMC7863024 | biostudies-literature
UnknownPharmacogenetics of alcohol addiction: current perspectives.
Not available
S-EPMC6628972 | biostudies-literature
UnknownInfluence of Plasma Concentration of Hsa-Mir-370-3p and Cyp2d6*4 On Equilibrium Concentration of Phenazepam in Patients with Recurrent Depressive Disorder.
Not available
S-EPMC8601761 | biostudies-literature
UnknownInfluence of CYP2C19*17 Genetic Polymorphism on the Steady-State Concentration of Escitalopram in Patients with Recurrent Depressive Disorder.
Not available
S-EPMC9235311 | biostudies-literature
UnknownThe correlation between CYP2D6 isoenzyme activity and haloperidol efficacy and safety profile in patients with alcohol addiction during the exacerbation of the addiction.
Not available
S-EPMC5028170 | biostudies-literature
Sort   by:  
 Page size